Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State

Bacterial meningitis and septicemia caused by <i>Neisseria meningitidis</i> is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of <i>N. meningitidis</i> serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. <i>N. meningitidis</i> serogroup Y is of particular concern because these strains demonstrate higher levels of resistance to the antimicrobials ciprofloxacin and penicillin. At the Wadsworth Center Bacteriology Laboratory (WCBL), all <i>N. meningitidis</i> isolates received are identified, serogroup determined by real-time PCR, and antimicrobial susceptibility testing is performed. A subset of isolates undergo whole genome sequencing (WGS) to determine the multilocus sequence type (MLST), presence of antimicrobial resistance genes, and relatedness analysis for outbreak investigations. In this study, we sequenced all 36 <i>N. meningitidis</i> serogroup Y isolates received between 2018 and 2024, of which 20 (~55%) were determined to be sequence type (ST) 1466. We used multiple bioinformatic methods to characterize the relatedness of isolates received at WCBL and compared them with ST1466 isolates from the United States with publicly accessible genomes. We identified a cluster of 8 cases of ST1466 <i>N. meningitidis</i> from the same region of New York State (NYS) that included a known transmission event linked to sharing a cigarette. Cases in this cluster were comprised of predominantly unvaccinated, African American, non-Hispanic, males between 45 and 76 years old, and mostly presented with sepsis; a demographic and clinical presentation not typical of those affected by <i>N. meningitidis</i> in the United States. Comparisons with publicly available genomes from ST1466 <i>N. meningitidis</i> strains from across the country showed that relatedness methods that mask genomic regions showing recombination signatures can obscure the diversity among these strains. This study, which importantly includes a case of known recent transmission, highlights the need to revisit genomic relatedness estimation and thresholds for defining relatedness in <i>N. meningitidis</i>. Our results also illuminate the importance of surveillance and characterization of <i>N. meningitidis</i> for future prevention and treatment, and the increased resolution that WGS provides to surveillance efforts.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-01-22
DOI
https://doi.org/10.3389/fpubh.2025.1709761
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State

Kimberlee A. Musser, Anna Kidney, Krithivasan Sankaranarayanan, Andrew C. Peifer et al.
Frontiers in Public Health
Bacterial Infections and Vaccines
article

Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State

Kimberlee A. Musser, Anna Kidney, Krithivasan Sankaranarayanan, Andrew C. Peifer, Catharine Prussing, Evan Owens, Elizabeth Owuor Bielli, Kate T Wahl, Aaditya Ojha, Kara Mitchell, Wolfgang Haas, Caila B. Vaughn
article en

Abstract

Bacterial meningitis and septicemia caused by <i>Neisseria meningitidis</i> is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of <i>N. meningitidis</i> serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. <i>N. meningitidis</i> serogroup Y is of particular concern because these strains demonstrate higher levels of resistance to the antimicrobials ciprofloxacin and penicillin. At the Wadsworth Center Bacteriology Laboratory (WCBL), all <i>N. meningitidis</i> isolates received are identified, serogroup determined by real-time PCR, and antimicrobial susceptibility testing is performed. A subset of isolates undergo whole genome sequencing (WGS) to determine the multilocus sequence type (MLST), presence of antimicrobial resistance genes, and relatedness analysis for outbreak investigations. In this study, we sequenced all 36 <i>N. meningitidis</i> serogroup Y isolates received between 2018 and 2024, of which 20 (~55%) were determined to be sequence type (ST) 1466. We used multiple bioinformatic methods to characterize the relatedness of isolates received at WCBL and compared them with ST1466 isolates from the United States with publicly accessible genomes. We identified a cluster of 8 cases of ST1466 <i>N. meningitidis</i> from the same region of New York State (NYS) that included a known transmission event linked to sharing a cigarette. Cases in this cluster were comprised of predominantly unvaccinated, African American, non-Hispanic, males between 45 and 76 years old, and mostly presented with sepsis; a demographic and clinical presentation not typical of those affected by <i>N. meningitidis</i> in the United States. Comparisons with publicly available genomes from ST1466 <i>N. meningitidis</i> strains from across the country showed that relatedness methods that mask genomic regions showing recombination signatures can obscure the diversity among these strains. This study, which importantly includes a case of known recent transmission, highlights the need to revisit genomic relatedness estimation and thresholds for defining relatedness in <i>N. meningitidis</i>. Our results also illuminate the importance of surveillance and characterization of <i>N. meningitidis</i> for future prevention and treatment, and the increased resolution that WGS provides to surveillance efforts.

Frontiers in Public HealthVol. 13
New York State Department of Health (US), Wadsworth Center (US)
Centers for Disease Control and Prevention
Good health and well-being
Openalex Percentile: Top 80%
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.